Forrest Wall, MD
Plastic and Reconstructive Surgery · Shreveport, LANPI 1699758474
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 26.8% of the total. Reporting peaked in 2021 at $826 and has fallen 71.7% since, to $233 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in LA, where the typical reported total is $2,109.
Across 72 payments — averaging $29.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$565
- Sanara Medtech Inc.$401
- Kerecis Limited$207
- Sientra, Inc.$199
- Johnson & Johnson$185
- Heron Therapeutics, Inc.$124
- plus $427 from 13 others
What the payments were for
- Food & beverage$2,109100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $565 |
| Sanara Medtech Inc. | 13 | $401 |
| Kerecis Limited | 4 | $207 |
| Sientra, Inc. | 3 | $199 |
| Johnson & Johnson | 10 | $185 |
| Heron Therapeutics, Inc. | 1 | $124 |
| Stryker | 1 | $57 |
| Atricure, Inc. | 1 | $48 |
| Kowa Pharmaceuticals America, Inc. | 3 | $45 |
| Mimedx Group, Inc. | 1 | $44 |
| Novartis | 2 | $40 |
| Integra Lifesciences Corporation | 1 | $35 |
| UCB, Inc. | 1 | $35 |
| Acelrx Pharmaceuticals, Inc. | 2 | $30 |
| Smith+Nephew | 1 | $23 |
| Incyte Corporation | 1 | $22 |
| Covidien LP | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Medela LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,109 in reported general payments places this provider in the 50th percentile of 45 plastic and reconstructive surgery providers in Louisiana.
See all plastic and reconstructive surgery providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $195 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Shreveport
- Simeon WallShreveport$56K
- Holly WallShreveport$11K
- Paul DavisShreveport$655
- Mary KimShreveport$609
- Stephen RameyShreveport$268
- Daniel KnightShreveport$172
- John ValiulisShreveport$28
- David JansenMetairie$12K
- John GusteMetairie$10K
- Omer KaymakcalanNew Orleans$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.